|29.87||+0.4000||+1.36%||Vol 287.06K||1Y Perf 82.26%|
|Apr 23rd, 2021 10:42 DELAYED|
|- -%||- -|
|Target Price||35.67||Analyst Rating||Moderate Buy 1.56|
|Potential %||19.34||Finscreener Ranking||★ 40.98|
|Insiders Trans % 3/6/12 mo.||-/-100/66||Value Ranking||☆ 34.37|
|Insiders Value % 3/6/12 mo.||-/-100/96||Growth Ranking||★ 34.62|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-100/97||Income Ranking||— -|
|Market Cap||10.62B||Earnings Rating||Neutral|
|Price Range Ratio 52W %||75.28||Earnings Date||4th May 2021|
Today's Price Range
5 Year PE Ratio Range
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||4th May 2021|
|Estimated EPS Next Report||0.95|
|EPS Growth Next 5 Years %||13.10|
|Avg. Weekly Volume||1.76M|
|Avg. Monthly Volume||2.01M|
|Avg. Quarterly Volume||4.59M|
Bausch Health Companies Inc. (NYSE: BHC) stock closed at 29.47 per share at the end of the most recent trading day (a -0.27% change compared to the prior day closing price) with a volume of 979.01K shares and market capitalization of 10.62B. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 21600 people. Bausch Health Companies Inc. CEO is Joseph C. Papa.
The one-year performance of Bausch Health Companies Inc. stock is 82.26%, while year-to-date (YTD) performance is 41.68%. BHC stock has a five-year performance of -18.09%. Its 52-week range is between 14.86 and 34.8, which gives BHC stock a 52-week price range ratio of 75.28%
Bausch Health Companies Inc. currently has a PE ratio of -18.20, a price-to-book (PB) ratio of 19.95, a price-to-sale (PS) ratio of 1.76, a price to cashflow ratio of 9.60, a PEG ratio of 2.32, a ROA of -1.65%, a ROC of -1.79% and a ROE of -66.18%. The company’s profit margin is -6.74%, its EBITDA margin is 30.20%, and its revenue ttm is $5.90 Billion , which makes it $16.58 revenue per share.
Of the last four earnings reports from Bausch Health Companies Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $0.95 for the next earnings report. Bausch Health Companies Inc.’s next earnings report date is 04th May 2021.
The consensus rating of Wall Street analysts for Bausch Health Companies Inc. is Moderate Buy (1.56), with a target price of $35.67, which is +19.34% compared to the current price. The earnings rating for Bausch Health Companies Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Bausch Health Companies Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Bausch Health Companies Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 27.82, ATR14 : 1.07, CCI20 : -91.47, Chaikin Money Flow : -0.07, MACD : 0.02, Money Flow Index : 30.68, ROC : -5.67, RSI : 57.94, STOCH (14,3) : 37.53, STOCH RSI : 0.37, UO : 43.20, Williams %R : -62.47), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Bausch Health Companies Inc. in the last 12-months were: Christina Ackermann (Option Excercise at a value of $0), John A. Paulson (Buy at a value of $166 503 072), Joseph C. Papa (Option Excercise at a value of $0), Joseph F. Gordon (Option Excercise at a value of $0), Paul S. Herendeen (Option Excercise at a value of $0), Sam Eldessouky (Option Excercise at a value of $0), Thomas Appio (Option Excercise at a value of $0), William D. Humphries (Option Excercise at a value of $2 169 352), William D. Humphries (Sold 156 526 shares of value $3 080 553 )
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.